AMLX
Amylyx Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$27.33
+3.76%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-63.6%
Return on equity
-57.5%
Return on assets
-66.3%
Return on invested capital
0.00x
Asset turnover
-$126.6M
Cash from operations
$2.00
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026